v3.26.1
General (Tables)
6 Months Ended
Jun. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
Derivative instruments measured at fair value and their classification in the condensed consolidated balance sheets are presented in the following table (in thousands):
 
 Assets (liabilities) as of June 30, 2026 (unaudited)Assets (liabilities) as of December 31, 2025
 Notional
Amount
Fair
Value
Notional
Amount
Fair
Value
Foreign exchange forward contract derivatives in cash flow hedging relationships for operating expenses included in prepaid expenses and other short-term assets$137,796 $24,978 $187,767 $21,605 
Foreign exchange forward contract derivatives in cash flow hedging relationships for operating expenses included in accrued expenses and other short-term liabilities$47,689 $(668)$— $— 
Foreign exchange forward contract derivatives in cash flow hedging relationships for operating expenses included in long-term other assets$52,534 $2,722 $123,959 $6,465 
Foreign exchange forward contract derivatives in cash flow hedging relationships for operating expenses included in long-term other liabilities$58,981 $(871)$— $— 
Foreign exchange forward contract derivatives in cash flow hedging relationships for revenues included in prepaid expenses and other short-term assets$105,697 $1,526 $— $— 
Foreign exchange forward contract derivatives in cash flow hedging relationships for revenues included in accrued expenses and other short-term liabilities$23,312 $(49)$128,132 $(2,515)
Foreign exchange forward contract derivatives in cash flow hedging relationships for revenues included in long-term other assets$130,852 $1,923 $— $— 
Foreign exchange forward contract derivatives in cash flow hedging relationships for revenues included in long-term other liabilities$— $— $185,688 $(1,691)
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income
Net gains (losses) related to cash flow hedges that were reclassified from accumulated other comprehensive income to the condensed consolidated statements of operations are presented in the following table (in thousands):

Three Months EndedSix Months Ended
 June 30,June 30,
 2026202520262025
(unaudited)
Revenues$(800)$305 $(1,468)$884 
Cost of revenues37 81 117 (111)
Research and development6,394 (869)11,122 (1,605)
Sales and marketing76 172 228 (309)
General and administrative1,917 (231)3,302 (427)
Financial income (expense), net(28)(795)201 (431)
Total net gain (loss) related to cash flow hedges
$7,596 $(1,337)$13,502 $(1,999)
Schedule of Cash, Cash Equivalents and Investments Cash equivalents and marketable securities consist of the following (in thousands):
 
 As of June 30, 2026
(unaudited)
 Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized Losses
Fair
Value
Cash equivalents    
Money market funds$165,885 $— $— $165,885 
Total$165,885 $— $— $165,885 
Marketable securities
US Treasury securities$426,882 $144 $(552)$426,474 
Total$426,882 $144 $(552)$426,474 
Long-term marketable securities
US Treasury securities$213,911 $— $(651)$213,260 
Total$213,911 $— $(651)$213,260 


 As of December 31, 2025
 Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized Losses
Fair
Value
Cash equivalents    
Money market funds$120,155 $— $— $120,155 
Total$120,155 $— $— $120,155 
Marketable securities
US Treasury securities$679,959 $1,267 $(1)$681,225 
Total$679,959 $1,267 $(1)$681,225 
Long-term marketable securities
US Treasury securities$186,971 $231 $— $187,202 
Total$186,971 $231 $— $187,202